| Literature DB >> 31793449 |
Fadl H Veerankutty1, Nandu Nair1, Sidharth Chacko1, Vipin I Sreekumar1, Deepak Varma1, Prakash Kurumboor1.
Abstract
BACKGROUND: Laparoscopic resection for rectal cancer (LRR) has gained popularity because of better short-term outcomes and less post-operative morbidity. However, LRR is still not endorsed as a standard of care mainly due to concerns centred on oncological safety in comparison with open approach. Moreover, two recent randomised trials (Australian Laparoscopic Cancer of the Rectum [ALaCaRT] and the American College of Surgeons Oncology Group [ACOSOG] Z6051) have failed to prove that LRR is non-inferior to open resection. Studies on oncological adequacy of LRR in the Indian population in terms of quality of mesorectal excision are scarce. In this article, we aim to audit the oncological adequacy of LRR in our centre and thereby critically analyse the reliability of extrapolation of results of ALaCaRT and ACOSOG trials to the Indian population.Entities:
Keywords: Circumferential resection margin; colorectal neoplasms; laparoscopy; minimally invasive surgery; quality of surgery; rectal cancer; total mesorectal excision
Year: 2020 PMID: 31793449 PMCID: PMC7440015 DOI: 10.4103/jmas.JMAS_272_18
Source DB: PubMed Journal: J Minim Access Surg ISSN: 1998-3921 Impact factor: 1.407
Figure 1Laparoscopic abdominoperineal excision specimen with smooth intact mesorectal excision and no coning
Grading of the quality of mesorectum
| Complete | Nearly complete | Incomplete |
|---|---|---|
| Smooth intact bulky mesorectum | Moderate bulk to the mesorectum | Little bulk to the mesorectum |
| Mesorectal defects not deeper than 5 mm | Defects >5 mm, but none extending to the muscularis propria | Exposed muscularis propria |
| No coning | Moderate coning | Moderate to marked coning |
| Smooth regular CRM# | Irregular CRM# | Irregular CRM# |
#circumferential margin
Patient characteristics in our study (n=157)
| Age* | 61.53±9.86 (24-86) |
|---|---|
| Sex | |
| Males | 87 |
| Females | 47 |
| BMI# | 24.07±4.6 (14.97-47.09) |
| ASA$ | |
| I | 16 (10.19%) |
| II | 96 (61.15%) |
| III | 45 (28.66%) |
| Tumor location (%) | 36 (22.93%) |
| Upper rectum | |
| Middle rectum | 50 (31.85%) |
| Lower rectum | 71 (45.22%) |
| Neoadjuvant therapy | 107 (68.15%) |
| Laparoscopic anterior resection | 139 (88.54%) |
| Abdominoperineal resection | 18 (11.46%) |
| Operative duration (minutes)* | 183.4±61.8 (128-230) |
*Mean±Standard deviation (range), #BMI: Body mass index, $ASA: American Society of Anesthesiologists
Pathological analysis of patients in our study (n=157)
| Pathological T Stage (%) | |
|---|---|
| T0 | 11 (7.01%) |
| T1 | 18 (11.5%) |
| T2 | 41 (26.11%) |
| T3 | 77 (49.04%) |
| T4 | 10 (6.37%) |
| Pathological outcome | |
| Negative CRM# (%) | 151 (96.18%) |
| Completeness of TME$ (%) | |
| Complete | 148 (94.26%) |
| Nearly complete | 7 (4.46%) |
| Incomplete | 2 (1.27%) |
| Negative distal margin (%) | 155 (98.73%) |
| Average nodal harvest* | 19.86±9.28 (8-60) |
#CRM: Circumferential margin, $TME: Total mesorectal excision, *Mean±Standard deviation (range)